ClinicalTrials.gg

Neoplasm Metastasis clinical trials

The registry lists 4,048 studies for Neoplasm Metastasis across more than 10 countries. 891 are recruiting or about to start. 1,468 of them are mainly about Neoplasm Metastasis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-17. Counting its 3 narrower conditions too, such as Neoplastic Cells, Circulating: 4,552 studies, 1,032 open.

ClinicalTrials.gov finds 22,901 studies for Neoplasm Metastasis. How that becomes 4,045 here

This page counts the studies the registry files under Neoplasm Metastasis, and those it files under no condition that list Neoplasm Metastasisthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 15, 2026. How condition pages count

  1. 22,901Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −503Filed under a narrower condition, counted on its own pageNeoplastic Cells, Circulating 207 · Lymphatic Metastasis 202 · Neoplasms, Unknown Primary 94
  3. −1,312List Neoplasm Metastasis as a condition, but the registry did not file them under itMost often written as “Brain Metastases” (328), “Liver Metastases” (208), and “Bone Metastases” (79). The registry filed 14 of them under no condition at all, and the others under other conditions only, most often Brain Neoplasms (474) and Colorectal Neoplasms (210).
  4. −17,163Match it another way1,316 name it in the title, 243 in a keyword, and 15,604 by a synonym or other text the search reads.
  5. 3,923Counted here and found by its search317 of them list Neoplasm Metastasis in their own words; the registry filed them under no condition.
  6. +122
    Counted here, but its search does not find themThe first 20 of 122.
  7. 4,045The count on this page

Get an email when these change. Save the Neoplasm Metastasis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Status

Completed
1,715
Recruiting
691
Terminated
577
Status unknown
398
Active, not recruiting
297
Not yet recruiting
185

Phase

Phase 2
1,593
Phase 1
1,364
Phase 3
369
Phase 4
62
Early Phase 1
39

Where

United States
2,055
France
542
China
485
Spain
414
Canada
353
Italy
352

What is being tested here

Drugs under test in Neoplasm Metastasis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here Immune checkpoint inhibitors 47 open · Tyrosine kinase inhibitors (TKIs) 43 open · Antibody-drug conjugates (ADCs) 21 open · Antimetabolites 18 open · Angiogenesis inhibitors 8 open

Coming up

380studies finish main data collection within a year21 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 691 Neoplasm Metastasis studies recruiting now, 538 (78%) set no upper age limit and 97 (14%) stop at 75 or younger. 48 (7%) take children under 18. 35 (5%) are for women only and 27 (4%) for men only; 18 (3%) take healthy volunteers.

Recruiting studies that take each age, of 691
AgeWomenMen
1028 (4%)30 (4%)
18641 (93%)631 (91%)
30656 (95%)646 (93%)
40654 (95%)645 (93%)
50650 (94%)643 (93%)
65647 (94%)641 (93%)
75625 (90%)623 (90%)
85543 (79%)552 (80%)

Across all 4,048 studies, recruiting or not: 11% stop at 75 or younger and 2% at 65; 7% take children; 8% are for women only and 5% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Neoplasm Metastasis studies take

Of 498 phase 1 interventional studies under Neoplasm Metastasis, half reached primary completion within 54 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 154 mo33–83 · 498 studies48 mo28–75 · 288 studies62 mo40–98 · 210 studies
Phase 1/262 mo41–89 · 213 studies56 mo41–89 · 127 studies65 mo43–90 · 86 studies
Phase 256 mo33–83 · 443 studies33 mo26–63 · 88 studies60 mo36–90 · 355 studies
Phase 2/356 mo43–98 · 27 studies——
Phase 349 mo36–66 · 138 studies41 mo34–57 · 83 studies59 mo49–108 · 55 studies
Phase 453 mo22–68 · 24 studies——
Interventional, no phase54 mo28–91 · 316 studies—58 mo28–93 · 291 studies
Observational66 mo35–172 · 242 studies—75 mo36–172 · 211 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 18, 2026.

Started recruiting13

Show 8 more

Newly registered25

Show 20 more

Studies

Recruiting first, then most recently updated. Showing 50 of 4,048. Browse all 4,048 → or search them.